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TCTAP A-125
Leukocyte Post Primary Percutaneous Coronary Intervention as Predictor
of Left Ventricle Systolic Function in Patient with ST Elevation Myocardial
Infarction
Kabul Priyantoro,1 Daniel Parningotan Tobing1
1Harapan Kita Hospital, Indonesia
BACKGROUND The dynamic of coronary microcirculation post pri-
mary percutaneous coronary intervention (PPCI), which achieves
steady state after 12-48 hours, is inﬂuenced by many factors, one of
them is inﬂammation, and this condition has been correlated with
clinical outcome. The aim of this study was to see the correlation
between total leucocytes count 48 hours post PPCI with short term
improvement of left ventricle (LV) function.
METHODS Of total 103 STEMI subjects whom underwent PPCI, 62
subjects were included completely from Jan to Apr 2013, and followed
until 30 days. Total leucocyte count was measured during admission
and 48 hours post PPCI. Subjects divided in two groups, group with
total leucocyte count 48 hours post PPCI >12,020/uL and group with
total leucocyte count 48 hours post PPCI < 12,020/uL. TIMI ﬂow and
myocardial blush grade were measure immediately post PPCI. LV
systolic function was measured using regional wall motion index
(RWMI) focusing on infarct related artery (IRA) by echocardiography,
soon after PPCI and at 30 days. Intra and inter observer variability
were analyzed. Logistic regression was used to correlate variables
using software Stata ver 12.
RESULTS Patients with total leukocyte count 48 hours post PPCI
>12,020/uL, had OR 4,4 (95% CI:0,98–19,85; p¼0,05) to have irre-
versible segmental LV function in IRA territory at 30 days. Multivar-
iate analysis consistently shown leukocyte post PPCI as strong
predictor of RWMI irreversibility, with OR5,6 (95% CI:1,08–
28,6;p¼0,039).
CONCLUSION High total leukocyte counts 48 hours post PPCI
(> 12,020/uL), can predict irreversible recovery of segmental LV
function in IRA territory at 30 days.
TCTAP A-126
ST-Segment Elevation in Lead aVR as the Predictive Value in Acute
Coronary Syndromes
Zhen Guo Ji1
1The Third Hospital of Shijiazhuang City, China
BACKGROUND This study aimed to analyze the prognostic value of
the presence of ST elevation in lead aVR in initial standard electro-
cardiogram (ECG) performed on admission in combination with clin-
ical variables for acute coronary syndromes (ACS).
METHODS In 446 consecutive patients with ACS, we evaluated
admission ECG for aVR and divided patients into two groups: group A
(254 patients with non-ST elevation in aVR) and group B (192 patients
with ST elevation). The clinical and the coronary angiographic data
were compared.
RESULTS 1) There was no signiﬁcant difference in age, gender,
smoking, hypertension, hyperlipidemia and diabetes between two
groups. 2) There were more patients with left main lesion and triple
vessel lesion in group B (24/192 and 36/192) than group A (11/254,31/
254, p value ¼0.01 for left main lesion and 0.055 for triple vessel
lesion). 3) Survival analysis: The death in group A and group B was
28 (11.02%) and 35 (18.23%, p¼0.031), respectively. The overall sur-
vival rate of group A was signiﬁcantly higher than that of group B (log-
rank test, p¼ 0.026, Kaplan-Meier survival cure seen at graph 1). 4)
Cox regression analysis showed that patient mortality hazard in ST
elevation of aVR was 1.745045 folds of patients with non-ST elevation
(p¼0.0275).CONCLUSION ST-segment elevation in lead aVR has a diagnostic and
prognostic value in patients with ACS and may provide an additional
prognostic value to the conventional cardiovascular risk factor.
TCTAP A-127
Transradial Versus Transfemoral Primary Percutaneous Coronary
Intervention for Acute ST-Segment Elevation Myocardial Infarction
Deuk-Young Nah,1 Jun-Ho Bae,1 Jin Wook Chung1
1Dongguk University Gyeongju Hospital, Korea (Republic of)
BACKGROUND Recent several studies suggest better clinical outcome
of the transradial intervention (TRI) for primary percutaneous coro-
nary intervention (PPCI) for acute ST-segment elevation myocardial
infarction (acute STEMI). The purpose of this study was to determine
whether TRI for acute STEMI is associated with better outcome and
safety compared with transfemoral artery intervention (TFI) in real-
world practice.
METHODS We analyzed 271 consecutive acute STEMI patients (age
63.513.1, 73.4% of male) underwent PPCI in Dongguk University
Gyeongju hospital and the patients with cardiogenic shock were also
included in this study. The number of patients of TRI was 113
(61.613.7 years, 84.1% of male) and TFI was 158 (64.912.4 years,
65.8% of male). We compared between TRI and TFI in terms of death
in 48 hours after admission and bleeding (hemoglobin decreased more
than 4 g/dl and RBC transfusion).
RESULTS There were no differences of catheterization laboratory to
needle time (8.05.3 min vs. 9.25.3 min, p¼0.058) and procedure
success rate (92% vs. 96%, p¼0.114) between TRI group and TFI group.
Mortality in the TRI group and TFI group was 8.0% versus 6.7%
(p¼0.387) at 48 hours after admission and 8.0% versus 11.4%
(p¼0.236) at 30 days. However, the incidence of bleeding was lower in
TRI group than TFI group (0% vs. 7.0%, p¼0.002). In binary logistic
regression analysis, TRI for acute STEMI was not independent pre-
dictor of mortality but left main and triple vessel disease was only
independent predictor for mortality (10.73, 95% CI, 3.78w30.41).
CONCLUSION Our study shows that TRI for acute STEMI did not
reduced mortality at 48 hours and 30 days after admission but
decreased bleeding complications. In experienced operator for both
access sites, the TRI for acute STEMI is the one of the option for
reduction of access site and bleeding complication.
TCTAP A-128
Impact of Regional Differences on Cardiovascular Outcome in Patients
Undergoing Coronary Angiography or Intervention in Acute Coronary
Syndrome: A Population-Based Study from NHIRD of Taiwan
Chun-Yuan Chu,1 Wen-Hsien Lee,1 Po-Chao Hsu,1 Ho-Ming Su,1
Hung-Hao Lee,1 Cheng-An Chiu,1 Tsung-Hsien Lin,1 Wen-Chol Voon,1
Wen-Ter Lai,1 Sheng-Hsiung Sheu1
1Kaohsiung Medical University Hospital, Taiwan
BACKGROUND Patients with acute coronary syndromes (ACS) un-
dergoing coronary angiography (CAG) or percutaneous coronary
intervention (PCI) are shown to have better outcome. Although the
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differences (RD) on ACS subjects0 outcomes are unclear in the real
world practice.
METHODS Data were analyzed from the 2005-2008 National Health
Insurance Research Database (NHIRD) in Taiwan. ACS subjects un-
dergoing CAG or PCI with intent to revascularization during the same
admission were enrolled. The major adverse cardiac events (MACE)
were cardiovascular death, myocardial infarction (MI) and stroke.
Other exploratory endpoint is heart failure (HF). RD was deﬁned as
cardiovascular outcomes between two geographic locations.
RESULTS 2481 patients with ACS were enrolled and the mean age was
65.012.9 years old. We found RD including admission charge, length
of hospital stay, and the percentage of hyperlipidemia, beta-blockers
use, angiotensin-converting-enzyme inhibitors (ACEI) use, and CAG.
Cox regression analysis showed that RD was associated with MACE
(P¼0.012) and MI (P¼0.005), but not HF (P¼0.094), cardiovascular
death (P ¼0.551) or stroke (P ¼0.733). Kaplan–Meier curves showed
two locations had signiﬁcant difference among MACE and MI (both
log-rank test p < 0.012). In the multivariate analysis, RD was associ-
ated with MACE (P ¼0.006) and MI (P ¼0.002).CONCLUSION In the real-world practice, RD might be an outcome
predictor of MACE and MI in ACS subjects.
Key words: acute coronary syndrome, regional difference, coronary
angiography, MACE, PCITCTAP A-129
Time of Onset of Acute Myocardial Infarction to First Balloon Dilatation and
T Wave Alternans
Dian Larasati Munawar1
1Binawaluya Cardiac Center, Indonesia
BACKGROUND T-wave alternans (TWA) is a heart rate dependent
repolarization measurement and correlates with arrhythmia
vulnerability in animal and human studies. TWA is one of estab-
lished marker and can predict individuals at high risk of devel-
oping a potentially lethal cardiac arrhythmia. We evaluate the
association of onset of myocardial infarction and increased of TWA
in patients with acute ST-segment elevation myocardial infarction
(STEMI).
METHODS All patients with acute STEMI who underwent primary
percutaneous coronary intervention (PPCI) at Bina Waluya Cardiac
Center in periods of January 2011 to October 2011 were enrolled.
Those were having previous myocardial infarction was excluded.
TWA was measured using Treadmill test after 1 to 2 weeks after
discharge.
RESULTS A total of consecutive 27 patients were included in the
study. There were 25 man and 2 women, with the mean age 58.8 
9.9years. The median onset of STEMI and ﬁrst medical contact was 5.2
hours (0.5 to 11 hours) and the mean door to balloon was 149.5  97.8
minutes (62 to 432 minutes). The time between onsets of myocardial
infarction to the ﬁrst balloon dilatation was so-called pre-revascular-
ization time. No complication occurred. The mean LV EF was 59 
13.2% and End Diastolic Diameter (EDD)was 499.5 mm, and the End
Systolic Diameter (ESD) was 329.7 mm. There was signiﬁcant corre-
lation between pre-revascularization time and the TWA (r¼0.51,
p<0.01). The longer the pre-revascularization time, the longer the
TWA.
CONCLUSION The longer the pre-revascularization times the more
probability of having higher results of TWA and may inﬂuence
occurring of ventricular arrhythmia.
TCTAP A-130
Very Long-Term Outcomes After Stenting Using Sirolimus- and Paclitaxel-
Eluting Stents for Patients with First STEMI: A Propensity-Score Matched
Analysis
Tetsuya Ishikawa,1 Makoto Muto1
1Saitama Prefectural Cardiovascular and respiratory Disease Center,
Japan
BACKGROUND We conducted a retrospective examination of very
long-term clinical outcomes after stenting using sirolimus (SES) and
paclitaxel (PES)-eluting stents for patients with STEMI presented
within 48hrs from the onset.
METHODS The present study was a non-randomized, retrospective,
and single center study, recruiting 872 ﬁrst STEMI patients after
successful either SES (n¼547)or PES placement during from November
2004 to April 2012.
RESULTS The incidence of severe cardiac events comprising of
cardiac death, nonfatal recurrent MI, and deﬁnite stent thrombosis
in the SES group (8.6%) during the follow-up duration of 2173786
(days) was not signiﬁcantly different from that in the PES group
(6.2%, 1821696 days). However, the incidence of very late deﬁnite
stent thrombosis (VLST) in the SES group (1.5%) was signiﬁcantly
greater than that in the PES group (0, p¼0.041). However, after
adjusting the 29 baselines by a propensity-score matched analysis
produced 231 patients in each arm, the incidence of severe cardiac
events including VLST (0.4%) in the SES group (5.6%) was not
signiﬁcantly different from that in the PES group (6.1%). Cox pro-
portional hazard model showed that patients with LMCA disease
(hazard ratio¼11.6, 95% CI: 1.98-68.1, p¼0.007) and ﬁnal TIMI-grade
ﬂow 2-3 (0.145, 95% CI: 0.025-0.83, p¼0.030) were the predictors of
severe cardiac events.
CONCLUSION Thus, very long-term clinical outcomes of the ﬁrst-
generation DESs (SES vs. PES) for ﬁrst STEMI patients were favorable
and statistically equivalent in Japan.
